Marcus Corporation reported better-than-expected Q1 results with $154.4M revenue and an EPS of -$0.51, driven by its Theatres division outperforming national box office growth. Theatres saw improved EBITDA margins due to higher ticket prices and strong family movie attendance. However, the Hotels division experienced margin pressure from weaker food, beverage, and ancillary revenues despite occupancy gains. The analyst maintains a Buy rating with a price target of $20–$23.50, expecting over 25% total return as theatre strength balances hotel weaknesses.
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million, with an additional earnout of up to €50 million based on performance. This acquisition will expand IPG's Advanced Solutions portfolio in medical lasers, particularl...
Constellation Software Inc. announced it will hold a conference call and live webcast on August 12, 2026, at 8:00 a.m. ET to discuss its second quarter results. The company will release its quarterly earnings after the Toronto Stock Exchange closes o...
XRP is trading in a tight range around $1.10, showing little price movement despite signals of large whale accumulation and increased derivatives activity. Regulatory developments in the US, including a congressional hearing on XRP's classification, ...
